Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Non-Small-Cell Lung 2Tongue Neoplasms 1Salivary Gland Neoplasms 1Recurrence 1Neoplasms 1Nasopharyngeal Carcinoma 1Lung Neoplasms 1Klatskin Tumor 1Cholangiocarcinoma 1Carcinoma, Large Cell 1Adenocarcinoma 1

Interventions

Docetaxel 3Carboplatin 3motexafin gadolinium 2figitumumab 2cemiplimab 2alpha-2'-deoxythioguanosine 2Paclitaxel 2vandetanib 1temoporfin 1tanespimycin 1brigatinib 1Vinorelbine 1Temozolomide 1Radiotherapy 1Radiosurgery 1Pemetrexed 1Oxaliplatin 1Gemcitabine 1Everolimus 1Erlotinib Hydrochloride 1Crizotinib 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Large Cell × temoporfin × Clear all
NCT01637376 2014-01-15

Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer

University of Arkansas

Phase 1 Withdrawn
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡